Lincoln Pharmaceuticals Limited has informed the Exchange about Schedule of Earnings Conference Call to discuss the unaudited financial results of the Company for the Quarter and Nine months ended December-2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has informed the stock exchanges that it will hold an investor earnings call on Wednesday, February 18, 2026, at 4:00 PM IST. The call will be led by Whole Time Director Mr. Munjal Patel and will cover the company's unaudited financial results for the quarter and nine months ended December 31, 2025. The call is being coordinated by DSNN Consultancy, and investors can register via the Diamond Pass link provided. The audio recording and transcript will subsequently be made available on the company's website under the investor disclosures section.
This is a routine regulatory disclosure and does not directly impact the stock price. Investors should watch the call for management commentary on Q3 FY26 performance, which could shape near-term sentiment around the stock.